Why Is CoreWeave Stock Down So Much?
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
Sell
41
WGS Quote, Financials, Valuation and Earnings
Last price:
$129.26
Seasonality move
:
46.27%
Day range:
$128.81 - $135.60
52-week range:
$55.17 - $170.87
Dividend yield:
0%
P/E ratio:
2,144.94x
P/S ratio:
9.22x
P/B ratio:
12.79x
Volume:
323.8K
Avg. volume:
427K
1-year change:
65.71%
Market cap:
$3.7B
Revenue:
$305.5M
EPS (TTM):
$0.06
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
WGS
GeneDx Holdings Corp.
|
$104.7M | $0.42 | 25.98% | -44.8% | $170.89 |
|
DCTH
Delcath Systems, Inc.
|
$25.3M | -$0.09 | 32.37% | -69.37% | $22.31 |
|
DGX
Quest Diagnostics, Inc.
|
$2.7B | $2.50 | 5.05% | 21.08% | $198.06 |
|
GH
Guardant Health, Inc.
|
$235.7M | -$0.49 | 32.68% | -47.37% | $114.05 |
|
ILMN
Illumina, Inc.
|
$1.1B | $1.17 | -0.1% | 4.82% | $125.28 |
|
LH
Labcorp Holdings, Inc.
|
$3.6B | $4.14 | 6.94% | 131.26% | $299.71 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
WGS
GeneDx Holdings Corp.
|
$129.34 | $170.89 | $3.7B | 2,144.94x | $0.00 | 0% | 9.22x |
|
DCTH
Delcath Systems, Inc.
|
$10.17 | $22.31 | $359.1M | 1,168.97x | $0.00 | 0% | 4.85x |
|
DGX
Quest Diagnostics, Inc.
|
$175.52 | $198.06 | $19.5B | 20.60x | $0.80 | 1.8% | 1.83x |
|
GH
Guardant Health, Inc.
|
$101.39 | $114.05 | $13.2B | -- | $0.00 | 0% | 13.94x |
|
ILMN
Illumina, Inc.
|
$134.48 | $125.28 | $20.5B | 30.13x | $0.00 | 0% | 4.94x |
|
LH
Labcorp Holdings, Inc.
|
$252.97 | $299.71 | $21B | 24.84x | $0.72 | 1.14% | 1.54x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
WGS
GeneDx Holdings Corp.
|
28.13% | 1.613 | 3.68% | 2.47x |
|
DCTH
Delcath Systems, Inc.
|
0.83% | 1.825 | 0.25% | 12.82x |
|
DGX
Quest Diagnostics, Inc.
|
46.79% | 0.203 | 30.05% | 0.90x |
|
GH
Guardant Health, Inc.
|
136.47% | 1.840 | 16.98% | 2.94x |
|
ILMN
Illumina, Inc.
|
51.97% | 2.433 | 17.73% | 1.04x |
|
LH
Labcorp Holdings, Inc.
|
42.88% | 0.863 | 27.39% | 1.10x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
WGS
GeneDx Holdings Corp.
|
$79.4M | -$3.1M | 0.56% | 0.82% | -2.68% | $9.6M |
|
DCTH
Delcath Systems, Inc.
|
$17.9M | -$388K | 1.56% | 1.59% | -1.89% | $4.3M |
|
DGX
Quest Diagnostics, Inc.
|
$911M | $420M | 7.41% | 14.33% | 14.92% | $419M |
|
GH
Guardant Health, Inc.
|
$171.6M | -$99M | -36.05% | -8518.58% | -37.33% | -$45.8M |
|
ILMN
Illumina, Inc.
|
$732M | $231M | 14.3% | 30.55% | 21.33% | $253M |
|
LH
Labcorp Holdings, Inc.
|
$955.6M | $403.2M | 5.61% | 10.25% | 11.32% | $280.5M |
GeneDx Holdings Corp. vs. Competitors
-
Which has Higher Returns WGS or DCTH?
Delcath Systems, Inc. has a net margin of -6.54% compared to GeneDx Holdings Corp.'s net margin of 4.04%. GeneDx Holdings Corp.'s return on equity of 0.82% beat Delcath Systems, Inc.'s return on equity of 1.59%.
Company Gross Margin Earnings Per Share Invested Capital WGSGeneDx Holdings Corp.68.04% -$0.27 $406.6M DCTHDelcath Systems, Inc.87.24% $0.02 $115.8M -
What do Analysts Say About WGS or DCTH?
GeneDx Holdings Corp. has a consensus price target of $170.89, signalling upside risk potential of 32.12%. On the other hand Delcath Systems, Inc. has an analysts' consensus of $22.31 which suggests that it could grow by 119.32%. Given that Delcath Systems, Inc. has higher upside potential than GeneDx Holdings Corp., analysts believe Delcath Systems, Inc. is more attractive than GeneDx Holdings Corp..
Company Buy Ratings Hold Ratings Sell Ratings WGSGeneDx Holdings Corp.7 1 0 DCTHDelcath Systems, Inc.5 0 0 -
Is WGS or DCTH More Risky?
GeneDx Holdings Corp. has a beta of 2.025, which suggesting that the stock is 102.538% more volatile than S&P 500. In comparison Delcath Systems, Inc. has a beta of 0.410, suggesting its less volatile than the S&P 500 by 59.033%.
-
Which is a Better Dividend Stock WGS or DCTH?
GeneDx Holdings Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Delcath Systems, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. GeneDx Holdings Corp. pays -- of its earnings as a dividend. Delcath Systems, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios WGS or DCTH?
GeneDx Holdings Corp. quarterly revenues are $116.7M, which are larger than Delcath Systems, Inc. quarterly revenues of $20.6M. GeneDx Holdings Corp.'s net income of -$7.6M is lower than Delcath Systems, Inc.'s net income of $830K. Notably, GeneDx Holdings Corp.'s price-to-earnings ratio is 2,144.94x while Delcath Systems, Inc.'s PE ratio is 1,168.97x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for GeneDx Holdings Corp. is 9.22x versus 4.85x for Delcath Systems, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income WGSGeneDx Holdings Corp.9.22x 2,144.94x $116.7M -$7.6M DCTHDelcath Systems, Inc.4.85x 1,168.97x $20.6M $830K
-
Which has Higher Returns WGS or DGX?
Quest Diagnostics, Inc. has a net margin of -6.54% compared to GeneDx Holdings Corp.'s net margin of 9.13%. GeneDx Holdings Corp.'s return on equity of 0.82% beat Quest Diagnostics, Inc.'s return on equity of 14.33%.
Company Gross Margin Earnings Per Share Invested Capital WGSGeneDx Holdings Corp.68.04% -$0.27 $406.6M DGXQuest Diagnostics, Inc.32.35% $2.15 $13.8B -
What do Analysts Say About WGS or DGX?
GeneDx Holdings Corp. has a consensus price target of $170.89, signalling upside risk potential of 32.12%. On the other hand Quest Diagnostics, Inc. has an analysts' consensus of $198.06 which suggests that it could grow by 12.84%. Given that GeneDx Holdings Corp. has higher upside potential than Quest Diagnostics, Inc., analysts believe GeneDx Holdings Corp. is more attractive than Quest Diagnostics, Inc..
Company Buy Ratings Hold Ratings Sell Ratings WGSGeneDx Holdings Corp.7 1 0 DGXQuest Diagnostics, Inc.7 10 0 -
Is WGS or DGX More Risky?
GeneDx Holdings Corp. has a beta of 2.025, which suggesting that the stock is 102.538% more volatile than S&P 500. In comparison Quest Diagnostics, Inc. has a beta of 0.618, suggesting its less volatile than the S&P 500 by 38.214%.
-
Which is a Better Dividend Stock WGS or DGX?
GeneDx Holdings Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Quest Diagnostics, Inc. offers a yield of 1.8% to investors and pays a quarterly dividend of $0.80 per share. GeneDx Holdings Corp. pays -- of its earnings as a dividend. Quest Diagnostics, Inc. pays out 39.15% of its earnings as a dividend. Quest Diagnostics, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios WGS or DGX?
GeneDx Holdings Corp. quarterly revenues are $116.7M, which are smaller than Quest Diagnostics, Inc. quarterly revenues of $2.8B. GeneDx Holdings Corp.'s net income of -$7.6M is lower than Quest Diagnostics, Inc.'s net income of $257M. Notably, GeneDx Holdings Corp.'s price-to-earnings ratio is 2,144.94x while Quest Diagnostics, Inc.'s PE ratio is 20.60x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for GeneDx Holdings Corp. is 9.22x versus 1.83x for Quest Diagnostics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income WGSGeneDx Holdings Corp.9.22x 2,144.94x $116.7M -$7.6M DGXQuest Diagnostics, Inc.1.83x 20.60x $2.8B $257M
-
Which has Higher Returns WGS or GH?
Guardant Health, Inc. has a net margin of -6.54% compared to GeneDx Holdings Corp.'s net margin of -34.97%. GeneDx Holdings Corp.'s return on equity of 0.82% beat Guardant Health, Inc.'s return on equity of -8518.58%.
Company Gross Margin Earnings Per Share Invested Capital WGSGeneDx Holdings Corp.68.04% -$0.27 $406.6M GHGuardant Health, Inc.64.71% -$0.74 $971.9M -
What do Analysts Say About WGS or GH?
GeneDx Holdings Corp. has a consensus price target of $170.89, signalling upside risk potential of 32.12%. On the other hand Guardant Health, Inc. has an analysts' consensus of $114.05 which suggests that it could grow by 12.48%. Given that GeneDx Holdings Corp. has higher upside potential than Guardant Health, Inc., analysts believe GeneDx Holdings Corp. is more attractive than Guardant Health, Inc..
Company Buy Ratings Hold Ratings Sell Ratings WGSGeneDx Holdings Corp.7 1 0 GHGuardant Health, Inc.17 0 0 -
Is WGS or GH More Risky?
GeneDx Holdings Corp. has a beta of 2.025, which suggesting that the stock is 102.538% more volatile than S&P 500. In comparison Guardant Health, Inc. has a beta of 1.579, suggesting its more volatile than the S&P 500 by 57.876%.
-
Which is a Better Dividend Stock WGS or GH?
GeneDx Holdings Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Guardant Health, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. GeneDx Holdings Corp. pays -- of its earnings as a dividend. Guardant Health, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios WGS or GH?
GeneDx Holdings Corp. quarterly revenues are $116.7M, which are smaller than Guardant Health, Inc. quarterly revenues of $265.2M. GeneDx Holdings Corp.'s net income of -$7.6M is higher than Guardant Health, Inc.'s net income of -$92.7M. Notably, GeneDx Holdings Corp.'s price-to-earnings ratio is 2,144.94x while Guardant Health, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for GeneDx Holdings Corp. is 9.22x versus 13.94x for Guardant Health, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income WGSGeneDx Holdings Corp.9.22x 2,144.94x $116.7M -$7.6M GHGuardant Health, Inc.13.94x -- $265.2M -$92.7M
-
Which has Higher Returns WGS or ILMN?
Illumina, Inc. has a net margin of -6.54% compared to GeneDx Holdings Corp.'s net margin of 13.85%. GeneDx Holdings Corp.'s return on equity of 0.82% beat Illumina, Inc.'s return on equity of 30.55%.
Company Gross Margin Earnings Per Share Invested Capital WGSGeneDx Holdings Corp.68.04% -$0.27 $406.6M ILMNIllumina, Inc.67.59% $0.97 $5B -
What do Analysts Say About WGS or ILMN?
GeneDx Holdings Corp. has a consensus price target of $170.89, signalling upside risk potential of 32.12%. On the other hand Illumina, Inc. has an analysts' consensus of $125.28 which suggests that it could fall by -6.84%. Given that GeneDx Holdings Corp. has higher upside potential than Illumina, Inc., analysts believe GeneDx Holdings Corp. is more attractive than Illumina, Inc..
Company Buy Ratings Hold Ratings Sell Ratings WGSGeneDx Holdings Corp.7 1 0 ILMNIllumina, Inc.7 8 1 -
Is WGS or ILMN More Risky?
GeneDx Holdings Corp. has a beta of 2.025, which suggesting that the stock is 102.538% more volatile than S&P 500. In comparison Illumina, Inc. has a beta of 1.438, suggesting its more volatile than the S&P 500 by 43.845%.
-
Which is a Better Dividend Stock WGS or ILMN?
GeneDx Holdings Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Illumina, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. GeneDx Holdings Corp. pays -- of its earnings as a dividend. Illumina, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios WGS or ILMN?
GeneDx Holdings Corp. quarterly revenues are $116.7M, which are smaller than Illumina, Inc. quarterly revenues of $1.1B. GeneDx Holdings Corp.'s net income of -$7.6M is lower than Illumina, Inc.'s net income of $150M. Notably, GeneDx Holdings Corp.'s price-to-earnings ratio is 2,144.94x while Illumina, Inc.'s PE ratio is 30.13x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for GeneDx Holdings Corp. is 9.22x versus 4.94x for Illumina, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income WGSGeneDx Holdings Corp.9.22x 2,144.94x $116.7M -$7.6M ILMNIllumina, Inc.4.94x 30.13x $1.1B $150M
-
Which has Higher Returns WGS or LH?
Labcorp Holdings, Inc. has a net margin of -6.54% compared to GeneDx Holdings Corp.'s net margin of 7.34%. GeneDx Holdings Corp.'s return on equity of 0.82% beat Labcorp Holdings, Inc.'s return on equity of 10.25%.
Company Gross Margin Earnings Per Share Invested Capital WGSGeneDx Holdings Corp.68.04% -$0.27 $406.6M LHLabcorp Holdings, Inc.26.82% $3.12 $15.2B -
What do Analysts Say About WGS or LH?
GeneDx Holdings Corp. has a consensus price target of $170.89, signalling upside risk potential of 32.12%. On the other hand Labcorp Holdings, Inc. has an analysts' consensus of $299.71 which suggests that it could grow by 18.48%. Given that GeneDx Holdings Corp. has higher upside potential than Labcorp Holdings, Inc., analysts believe GeneDx Holdings Corp. is more attractive than Labcorp Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings WGSGeneDx Holdings Corp.7 1 0 LHLabcorp Holdings, Inc.12 5 0 -
Is WGS or LH More Risky?
GeneDx Holdings Corp. has a beta of 2.025, which suggesting that the stock is 102.538% more volatile than S&P 500. In comparison Labcorp Holdings, Inc. has a beta of 0.989, suggesting its less volatile than the S&P 500 by 1.121%.
-
Which is a Better Dividend Stock WGS or LH?
GeneDx Holdings Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Labcorp Holdings, Inc. offers a yield of 1.14% to investors and pays a quarterly dividend of $0.72 per share. GeneDx Holdings Corp. pays -- of its earnings as a dividend. Labcorp Holdings, Inc. pays out 32.58% of its earnings as a dividend. Labcorp Holdings, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios WGS or LH?
GeneDx Holdings Corp. quarterly revenues are $116.7M, which are smaller than Labcorp Holdings, Inc. quarterly revenues of $3.6B. GeneDx Holdings Corp.'s net income of -$7.6M is lower than Labcorp Holdings, Inc.'s net income of $261.5M. Notably, GeneDx Holdings Corp.'s price-to-earnings ratio is 2,144.94x while Labcorp Holdings, Inc.'s PE ratio is 24.84x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for GeneDx Holdings Corp. is 9.22x versus 1.54x for Labcorp Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income WGSGeneDx Holdings Corp.9.22x 2,144.94x $116.7M -$7.6M LHLabcorp Holdings, Inc.1.54x 24.84x $3.6B $261.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Stan Druckenmiller Buy MercadoLibre Stock?
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Sell
14
SMX alert for Dec 30
SMX (Security Matters) Plc [SMX] is down 25.73% over the past day.
Buy
71
ZCSH alert for Dec 30
Grayscale Zcash Trust (ZEC) [ZCSH] is up 18.01% over the past day.
Buy
69
GDXU alert for Dec 30
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is up 5.83% over the past day.
